MentionFox
Home › funding signals › Elevate Clinical Research, Inc.
Form D · on the record

Elevate Clinical Research — $1M Form D filing, February 2026

Before you sell to, join or invest in Elevate Clinical Research, Inc.

MentionFox check on Elevate Clinical Research, Inc.: only 1 source on file so far (checked 5 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/elevate-clinical-research-inc-form-d-26000001

Check Elevate Clinical Research, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Elevate Clinical Research, Inc.?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Elevate Clinical Research, Inc. filed a Form D with the Securities and Exchange Commission on 2026-02-17.

Elevate Clinical Research, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 17, 2026. The filing reports $1M sold. Its industry group is Other Health Care. It names Devora Henderson (Executive Officer, Director), Patrick Feeney (Director) (SEC Form D, February 17, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

Patrick Feeney is also named on 1 other Form D filing ↓

Is this your company?

Key facts

Run the free check on Elevate Clinical Research, Inc. →

Sell to companies like Elevate Clinical Research, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Elevate Clinical Research, Inc.

New Form D on file · 2026-02-17 · the record

$1M
raise on the record
D
filing
7
investors in
TEXAS
based
Open the record →

What the record says

FilingForm D
Filed2026-02-17
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
Year formed2024
BasedAUSTIN, TEXAS
CIK2105683
Accession0002105683-26-000001

Pitching, partnering or investing alongside them? See who really runs and owns Elevate Clinical Research, Inc.

Watch Elevate Clinical Research, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on the people and the money behind Elevate Clinical Research, Inc., from the filings we hold.

The people on this filing

More raises like this

Other Health Care raises by companies based in Texas, filed within 90 days of this one, largest first.

What do you want to do with Elevate Clinical Research, Inc.?

Get the full cited report on Elevate Clinical Research, Inc.

What the filing shows about Elevate Clinical Research, Inc.

  • 7 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Elevate Clinical Research, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Elevate Clinical Research, Inc.'s address as 211 E 7TH Street, Ste 620, Austin, TX 78701.

Keep digging

Who else raised the same week in health care

What the filing says

  • Offered: an open-ended amount (the filing says Indefinite). Sold: $1,000,000. Left to sell: open-ended (Indefinite). (filing)
  • Investors: 7 had already invested. (filing)
  • Date of first sale: June 1, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “The total amount sold at the time of filing of this Form D will be no less than the amount indicated above.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Elevate Clinical Research, Inc. See pricing

Is Elevate Clinical Research, Inc. a real, registered company?

Elevate Clinical Research, Inc. is a registered filer with the SEC (CIK 2105683) and has filed since 2026-02-17. 1 filing is on record, the latest on 2026-02-17.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Elevate Clinical Research, Inc.?

Elevate Clinical Research, Inc.'s Form D of 2026-02-17 names Devora Henderson and Patrick Feeney as its officers, directors or promoters.

How much has Elevate Clinical Research, Inc. raised?

Its new offerings report $1M sold across 1 offering, as its own filings state.

Other Health Care · by week
This raise, $1M, filed week of Feb 16

Trailing twelve months. 865 filings in Other Health Care, totalled by week. The dot is this raise, $1M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Elevate Clinical Research, Inc.?

What the filing shows about Elevate Clinical Research, Inc.

  • 7 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Elevate Clinical Research, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Elevate Clinical Research, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Elevate Clinical Research, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-05 (elevateclinical.com).

RSS

Tools for this story

Each opens in a new tab, filled in for Elevate Clinical Research, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Elevate Clinical Research, Inc.: Raised $1M, Form D filed 2026-02-17
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/elevate-clinical-research-inc-form-d-26000001
Last updated 2026-11-05
Primary record: SEC filing 1 · SEC filing 2
Elevate Clinical Research raised $1M — SEC Form D filing, February 2026. MentionFox, 2026-11-05. https://mentionfox.com/funding/elevate-clinical-research-inc-form-d-26000001